Healthcare | September 22, 2021
MetroMedi ties up with BMS Fit Club for diabetes management
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Ind-Ra expects IPM revenue to grow over 12% YoY in FY22
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care
The segment delivered strong sales growth of 20% YoY
New treatment options are critical, as approximately half of all people with heart failure die within five years of diagnosis. Heart failure accounts for more than one million hospitalisations a year in the US
FDA approval of the first interchangeable biosimilar insulin will drive the US Insulin biosimilar market, says Kuick Research.
Subscribe To Our Newsletter & Stay Updated
